AIHTA - Publications - Search - High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer

Warmuth, M. and Johansson, T. (2010): High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer. Decision Support Document 37.

[thumbnail of DSD_37.pdf]
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

HIFU is a new, minimally-invasive method for the treatment of prostate cancer, which has been in use since 1993 (Ablatherm®-HIFU) and 1995 (Sonablate®-HIFU), respectively. With this method ultrasound waves are targeted at prostatic tissue via a transrectally inserted ultrasound probe, whereby prostatic tissue is destroyed by heat and replaced by scar tissue. However, even in international guidelines this new treatment option is not without controversy.

Item Type:Decision Support Document
Keywords:Ablatherm, HIFU, high-intensity focussed ultrasound, minimally-invasive, prostate cancer, Sonablate, transrectal, ultrasonic therapy
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
WB Practice of medicine > WB 515 Ultrasonic therapy
WJ Urogenital system > WJ 700-875 Male genitalia
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WO Surgery > WO 505 Minimally invasive surgical procedures
Series Name:Decision Support Document 37
Deposited on:14 Jul 2010 16:21
Last Modified:15 Jul 2020 17:44

Repository Staff Only: item control page